EP 4127239 A1 20230208 - THE USE OF A GENE PANEL TO DETERMINE THE TERATOGENIC POTENTIAL OF MESENCHYMAL AND PERINATAL TISSUE-DERIVED CELLS
Title (en)
THE USE OF A GENE PANEL TO DETERMINE THE TERATOGENIC POTENTIAL OF MESENCHYMAL AND PERINATAL TISSUE-DERIVED CELLS
Title (de)
VERWENDUNG EINES GENPANELS ZUR BESTIMMUNG DES TERATOGENEN POTENZIALS MESENCHYMALER UND PERINATALER GEWEBEABGELEITETER ZELLEN
Title (fr)
UTILISATION D'UN PANEL DE GÈNES POUR DÉTERMINER LE POTENTIEL TÉRATOGÈNE DE CELLULES DÉRIVÉES DU TISSU MÉSENCHYMATEUX ET PÉRINATAL
Publication
Application
Priority
- PL 43337420 A 20200327
- IB 2021052521 W 20210326
Abstract (en)
[origin: WO2021191853A1] The subject of the invention is a set of genes comprising at least one gene panel selected among: CDKN2A, CDH20, HAND2, PDGFR-α; or ALOX15, CDH9, DRD4, ESM1, HEY1, NKX2- 5; or FUT3, PROM1, COL2A1, FOXA1, MYO3B; or CLDN1, CPLX2, EOMES, FOXA2, HNF1B, HNF4A, LEFTY1, POU4F1; or TDGF1, DNMT3B, IDO1, NANOG, POUF5F1, SOX2; for use in the determination of the teratogenic potential of a mesenchymal cell (MSC) population or a perinatal cell population.
IPC 8 full level
C12Q 1/6881 (2018.01)
CPC (source: EP PL)
C12N 5/0665 (2013.01 - PL); C12Q 1/6881 (2013.01 - EP); C12Q 1/6886 (2013.01 - PL); C12Q 2600/142 (2013.01 - PL); C12Q 2600/158 (2013.01 - EP PL)
Citation (search report)
See references of WO 2021191853A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021191853 A1 20210930; EP 4127239 A1 20230208; PL 241520 B1 20221017; PL 433374 A1 20211004
DOCDB simple family (application)
IB 2021052521 W 20210326; EP 21726182 A 20210326; PL 43337420 A 20200327